Joint Replacement for Patients with HIV: Debunking Complication Myths

Joint Replacement for Patients with HIV: Debunking Complication Myths

Introduction & Epidemiology

Historically, the presence of Human Immunodeficiency Virus (HIV) infection was considered a significant contraindication to major elective orthopedic procedures, particularly total joint arthroplasty (TJA). Concerns primarily revolved around perceived elevated risks of periprosthetic joint infection (PJI), delayed wound healing, and other perioperative complications in an immunocompromised patient population. However, the landscape of HIV management has been fundamentally transformed by the advent and widespread adoption of highly active antiretroviral therapy (HAART), now commonly referred to as antiretroviral therapy (ART).

Modern ART regimens have dramatically improved the life expectancy and quality of life for People Living With HIV (PLWH), effectively converting a once fatal illness into a manageable chronic condition. As PLWH age, they increasingly present with comorbidities common in the general population, including end-stage degenerative joint disease. Furthermore, PLWH often experience a higher incidence of specific orthopedic conditions necessitating arthroplasty. Avascular necrosis (AVN), particularly affecting the femoral head, is notably prevalent in PLWH, driven by factors such as ART-induced dyslipidemia, direct viral effects, corticosteroid use, and chronic inflammation. Similarly, accelerated osteoarthritis and inflammatory arthritides are observed with greater frequency.

Contemporary evidence robustly challenges historical perceptions. Numerous studies have demonstrated that with proper patient selection and meticulous perioperative management, PLWH with well-controlled HIV infection (characterized by a suppressed viral load and an adequate CD4 cell count) achieve comparable clinical outcomes following TJA to their HIV-negative counterparts. This document aims to provide an exhaustive, evidence-based review of joint replacement in PLWH, emphasizing current best practices and dispelling outdated notions regarding surgical risk. The focus will be on the orthopedic surgeon's perspective, providing high-yield information for surgical planning, execution, and post-operative care.

Surgical Anatomy & Biomechanics

While the fundamental surgical anatomy and biomechanics of major joints remain consistent irrespective of HIV status, specific considerations for PLWH impact preoperative assessment, intraoperative technique, and implant selection. This section will primarily reference the hip and knee, as they are the most common sites for joint replacement.

Total Hip Arthroplasty (THA)

1. Anatomy : The hip joint is a synovial ball-and-socket joint formed by the articulation of the femoral head and the acetabulum of the pelvis. Key anatomical structures include the articular cartilage, joint capsule, numerous ligaments (iliofemoral, pubofemoral, ischiofemoral), and surrounding musculature (gluteal, adductor, iliopsoas, short external rotators). Major neurovascular structures include the femoral nerve and artery anteriorly, and the sciatic nerve posteriorly, along with the superior and inferior gluteal vessels.
2. Biomechanics : Successful THA hinges on restoring native hip biomechanics to optimize load transfer, joint stability, and range of motion while minimizing wear. Critical parameters include:
   • Center of Rotation : Medialization of the femoral head can reduce joint reactive forces.
   • Femoral Offset : Lateral offset influences abductor lever arm, affecting stability and limp.
   • Leg Length Discrepancy : Careful templating and intraoperative assessment are essential to avoid iatrogenic limb length differences.
   • Acetabular Component Orientation : Proper inclination (typically 40-45°) and anteversion (15-20°) are crucial for stability and minimizing impingement.
3. HIV-Specific Biomechanical Considerations :
   • Bone Quality : PLWH may exhibit reduced bone mineral density (osteopenia/osteoporosis) due to chronic inflammation, ART side effects (e.g., tenofovir disoproxil fumarate), vitamin D deficiency, and direct viral effects. This can compromise primary implant stability, especially for cementless components, and increase the risk of intraoperative and periprosthetic fractures. Bone fragility should inform implant choice (cemented vs. uncemented) and surgical technique (gentle reaming, prophylactic cerclage wires).
   • Avascular Necrosis (AVN) : As a common indication for THA in PLWH, AVN often leads to femoral head collapse and associated cystic changes or sclerosis, necessitating careful preoperative templating for bone stock deficiency and potential need for bone grafting. The acetabulum is typically less affected by AVN itself, but secondary osteoarthritis can develop.
   • Lipodystrophy : While less common with newer ART regimens, historical lipodystrophy (peripheral fat wasting) can alter superficial anatomical planes, potentially affecting incision placement and wound closure, though this rarely impacts deeper surgical dissection.

Total Knee Arthroplasty (TKA)

1. Anatomy : The knee is a hinge joint comprising the articulation of the distal femur, proximal tibia, and patella. Ligamentous stability is provided by the medial and lateral collateral ligaments (MCL, LCL) and the anterior and posterior cruciate ligaments (ACL, PCL). The quadriceps mechanism, including the patella and patellar tendon, is critical for extension. Neurovascular structures include the popliteal artery and vein, and the tibial and common peroneal nerves.
2. Biomechanics : TKA aims to restore mechanical alignment, balance soft tissues, and provide pain-free motion. Key principles include:
   • Alignment : Restoration of the mechanical axis of the limb (typically 0-3° varus). Precision in femoral and tibial cuts is paramount.
   • Soft Tissue Balancing : Equalizing flexion and extension gaps to ensure stability throughout the range of motion. This often involves release of collateral ligaments or posterior capsule.
   • Joint Line Restoration : Maintaining the native joint line minimizes patellofemoral issues and optimizes gait.
   • Patellar Tracking : Ensuring smooth patellar articulation within the trochlear groove.
3. HIV-Specific Biomechanical Considerations :
   • Bone Quality : Similar to the hip, osteopenia can affect tibial and femoral condylar bone stock, influencing implant fixation and primary stability. This is particularly relevant for press-fit components and can increase the risk of condylar fractures.
   • Inflammatory Arthritis : Some forms of inflammatory arthritis are more common or exacerbated in PLWH, leading to unique bone erosions or soft tissue contractures that may require specific releases or bone grafting during TKA.
   • Neuroarthropathy : Although rare, severe peripheral neuropathy, a complication of advanced HIV or certain ARTs, can lead to Charcot arthropathy, presenting unique challenges for TKA due to joint instability and bone destruction. This is often a relative contraindication.

Indications & Contraindications

The indications for total joint arthroplasty in PLWH largely mirror those in the general population, with specific emphasis on conditions more prevalent or severe in this demographic. Contraindications, particularly in the context of HIV, have evolved significantly with advancements in medical management.

Primary Indications for Joint Arthroplplasty (General & HIV-Specific)

1. Severe Degenerative Joint Disease (Osteoarthritis) : Unresponsive to conservative measures (pharmacotherapy, physical therapy, injections) and causing debilitating pain and functional limitation. PLWH may experience accelerated cartilage degeneration.
2. Avascular Necrosis (AVN) : A particularly common indication for THA and TSA (Total Shoulder Arthroplasty) in PLWH. AVN often progresses rapidly, leading to subchondral collapse and severe pain.
3. Inflammatory Arthritis : Rheumatoid arthritis, psoriatic arthritis, or other seronegative spondyloarthropathies, which can be more severe or difficult to manage in PLWH, leading to end-stage joint destruction.
4. Post-Traumatic Arthritis : Secondary to previous intra-articular fractures.
5. Failed Osteosynthesis or Previous Arthroplasty : Revision scenarios.

Contraindications (General & HIV-Specific)

General Absolute Contraindications:

• Active Local Infection : Current sepsis in the joint intended for arthroplasty.
• Active Systemic Infection : Untreated or uncontrolled bacteremia or fungemia.
• Skeletal Immaturity : Open physes.
• Severe Peripheral Vascular Disease : Leading to critically ischemic limb.
• Severe Neuropathic Arthropathy (Charcot Joint) : Often a relative contraindication, but can be absolute in severe cases due to high failure rates.
• Rapidly Progressive Neurological Disease : Precluding safe ambulation and rehabilitation (e.g., rapidly progressive muscular dystrophy, severe stroke).

HIV-Specific Considerations (Evolving Perspective):

Historically, low CD4 count (<200 cells/µL) and high viral load (>50 copies/mL) were considered absolute contraindications due to the presumed unacceptable risk of PJI and other complications. Current evidence dictates a revised approach :

• Controlled HIV Infection is NOT a Contraindication : With modern ART, a CD4 cell count >200-350 cells/µL (ideally >350 cells/µL) and an undetectable viral load (<50 copies/mL) are generally considered safe immunological parameters for elective arthroplasty. These patients demonstrate PJI rates comparable to the HIV-negative population.
• Relative Contraindications (requiring careful risk stratification and optimization) :
  • Uncontrolled HIV Disease : CD4 count <200 cells/µL, detectable or high viral load. These patients are at higher risk for opportunistic infections and overall perioperative morbidity. Elective surgery should be deferred until optimization of HIV status with ART, in close consultation with an infectious disease specialist.
  • Significant HIV-Related Comorbidities : Severe hepatic dysfunction (cirrhosis), renal disease (end-stage renal disease), severe cardiac disease, or malnutrition (albumin <3.0 g/dL) can independently increase surgical risk. These require aggressive medical optimization preoperatively.
  • Recent Opportunistic Infection : Suggests poor immune control; elective surgery should be deferred for several months after resolution and immune reconstitution.

Table: Operative vs. Non-Operative Indications for Joint Arthroplasty

Pre-Operative Planning & Patient Positioning

Meticulous preoperative planning is paramount for all arthroplasty procedures, but it takes on added complexity and importance in the context of PLWH. The focus extends beyond standard orthopedic assessments to a comprehensive medical and immunological optimization.

General Pre-Operative Planning

1. History and Physical Examination : Detailed assessment of joint pain, function, range of motion, neurovascular status. Thorough medical history, including specific questions about HIV diagnosis, ART regimen, duration of treatment, history of opportunistic infections, and any associated comorbidities (renal disease, liver disease, cardiovascular issues, osteoporosis, neuropathy).
2. Imaging :
   • Standard Radiographs : AP pelvis (for THA), AP/lateral/skyline views of the knee (for TKA), stress views if indicated. Critical for templating implant size, identifying bone defects, and assessing joint line.
   • Advanced Imaging : MRI or CT scans may be required for complex cases, severe bone loss, tumor rule-out, or precise evaluation of AVN.
   • Bone Mineral Density (BMD) : DEXA scan recommended for all PLWH undergoing arthroplasty, given the higher prevalence of osteopenia/osteoporosis.
3. Medical Optimization :
   • Cardiovascular : EKG, echocardiogram, cardiac stress testing if indicated. Higher rates of dyslipidemia and cardiovascular disease in PLWH.
   • Renal/Hepatic : Baseline chemistries, LFTs, renal function tests. ARTs can impact organ function.
   • Hematological : Complete blood count (CBC). Anemia is common in PLWH. Type and screen/crossmatch.
   • Nutritional Status : Prealbumin/albumin levels. Malnutrition significantly increases surgical risk. Nutritional supplementation should be initiated if indicated.
   • Diabetes Control : Strict glycemic control (HbA1c <7.0%) is crucial to minimize infection risk.
4. Templating : Digital or analog templating using calibrated radiographs to predict implant size, assess leg length, and anticipate any bone stock deficiencies. This guides intraoperative decision-making and reduces operative time.

HIV-Specific Pre-Operative Planning

1. Infectious Disease Consultation : Mandatory for all PLWH considering elective TJA. This specialist will:
   • Verify HIV status (CD4 count, viral load, ART regimen, resistance profiles).
   • Optimize ART regimen and ensure compliance. The goal is a CD4 count >200-350 cells/µL and an undetectable viral load (<50 copies/mL) for at least 3-6 months prior to surgery.
   • Advise on perioperative antibiotic prophylaxis, considering potential drug interactions with ARTs.
   • Manage opportunistic infections or reactivations.
2. Immunological Status Assessment :
   • CD4 Count : A critical biomarker of immune function. While specific thresholds vary, a CD4 count >200-350 cells/µL is generally accepted. Lower counts significantly increase infection risk.
   • Viral Load : Undetectable viral load is paramount, indicating effective ART and reduced systemic inflammatory burden.
3. Medication Review and Management :
   • ART Adherence : Reinforce strict adherence to ART pre- and post-operatively. Missed doses can lead to viral rebound and immune compromise.
   • Drug Interactions : Consult with pharmacy/infectious disease for potential interactions between ARTs and perioperative medications (e.g., anesthetics, analgesics, antibiotics, anticoagulants, antiemetics). For example, protease inhibitors and non-nucleoside reverse transcriptase inhibitors can affect metabolism of many drugs via cytochrome P450 pathways.
4. Bone Health Assessment and Optimization : Given higher rates of osteopenia/osteoporosis, consider preoperative vitamin D supplementation, calcium, and potentially bisphosphonates or other anti-resorptive agents in consultation with an endocrinologist. This proactive approach can improve bone quality and reduce fracture risk.
5. Anemia Management : Correct anemia preoperatively, as it is a risk factor for PJI and can necessitate transfusions, which carry their own risks. Erythropoietin-stimulating agents or iron supplementation may be considered.
6. Patient Counseling : Comprehensive discussion regarding realistic expectations, the importance of ART adherence, the specific risks related to HIV (even if minimized), and the commitment required for rehabilitation.

Patient Positioning

Standard positioning protocols for specific joints are generally followed, with an emphasis on preventing pressure sores and optimizing surgical exposure.

1. Total Hip Arthroplasty (THA) :
   • Posterior or Anterolateral Approaches : Lateral decubitus position. Careful padding of all bony prominences (sacrum, contralateral hip, knees, ankles, upper extremities) is essential. Ensure adequate axillary roll and head support.
   • Anterior Approach : Supine position, often on a specialized traction table. Careful attention to perineal padding and femoral nerve protection is critical.
2. Total Knee Arthroplasty (TKA) :
   • Supine Position : The leg is typically prepped free, allowing for full range of motion. A bolster beneath the ipsilateral hip can help internally rotate the limb. A tourniquet is routinely used for hemostasis, though its duration should be minimized, especially in patients with vascular comorbidities.

In PLWH, who may have neuropathies, fragile skin, or altered body habitus due to lipodystrophy, meticulous attention to pressure point padding and nerve protection is even more critical.

Detailed Surgical Approach / Technique (Total Hip Arthroplasty - Posterior Approach)

This section will detail the posterior approach for Total Hip Arthroplasty (THA) as a common and versatile technique. The principles of meticulous soft tissue handling, hemostasis, and precise bone preparation are universal to all arthroplasty procedures and are particularly important in PLWH.

General Principles

• Aseptic Technique : Stringent adherence to sterile protocols, including double gloving, comprehensive skin preparation, and laminar flow operating rooms (if available).
• Hemostasis : Meticulous dissection and cauterization to minimize blood loss, which can be critical in potentially anemic or coagulopathic patients.
• Soft Tissue Handling : Gentle retraction and sharp dissection to minimize tissue trauma, reducing inflammation and aiding wound healing.
• Bone Preparation : Precise cuts and reaming/broaching to ensure optimal implant fit and long-term stability.

Posterior Approach for THA (Step-by-Step)

1. Incision : A curvilinear or straight incision centered over the posterior aspect of the greater trochanter, extending 8-15 cm proximally and distally, depending on patient size and desired exposure. The incision courses slightly posterior to the greater trochanter.
2. Superficial Dissection : Incise the skin and subcutaneous tissue down to the fascia lata.
3. Fascia Lata Incision : Incise the fascia lata in line with the skin incision. The gluteus maximus fibers are then split longitudinally without formal detachment.
4. Deep Dissection & Short External Rotators :
   • Identify the greater trochanter and the confluence of the short external rotator muscles (piriformis, gemelli superior and inferior, obturator internus, quadratus femoris) inserting onto its posterior aspect.
   • Carefully dissect and detach these muscles from their insertions on the posterior greater trochanter. A cuff of tendon can be left on the trochanter for later repair.
   • The sciatic nerve typically lies deep and medial to the piriformis, running across the quadratus femoris. It is paramount to protect the sciatic nerve through meticulous blunt and sharp dissection, avoiding excessive retraction, especially in internal rotation.
5. Capsulotomy : The posterior capsule is identified. A T-shaped or inverted T-shaped capsulotomy is performed to expose the femoral head and acetabulum. The detached capsule can be tagged for later repair, contributing to posterior stability.
6. Hip Dislocation : The hip is dislocated by internally rotating and adducting the flexed femur. This maneuver requires controlled force to avoid iatrogenic fracture.
7. Femoral Neck Osteotomy :
   • Measure leg length and femoral head offset using calipers or dedicated measuring devices.
   • Perform a precise osteotomy of the femoral neck. The level of the osteotomy is critical for leg length and offset restoration, typically 1-2 fingerbreadths proximal to the lesser trochanter, but guided by preoperative templating and intraoperative measurements.
   • Remove the femoral head.
8. Acetabular Preparation :
   • Expose the acetabulum. Remove remaining labrum, osteophytes, and any loose bodies.
   • Ream the acetabulum incrementally, starting with a smaller reamer and progressing until bleeding subchondral bone is exposed, indicating adequate bone preparation. Ensure correct inclination (40-45°) and anteversion (15-20°) of the reamers. The anterior column and posterior column should be respected.
   • Impact the definitive acetabular component (cup). If using a press-fit cup, ensure adequate initial stability. Adjunctive screw fixation through pre-drilled holes in the cup may be used for additional stability, particularly in osteopenic bone, directing screws away from neurovascular structures.
   • Insert the trial liner.
9. Femoral Preparation :
   • Prepare the femoral canal using rasps (broaches) of increasing size, ensuring proper fit and fill within the proximal femur. This ensures primary stability of the femoral stem.
   • Ensure proper anteversion of the femoral component.
10. Trial Reduction :
    • Insert the trial femoral stem, trial head, and trial liner.
    • Perform a trial reduction. Assess hip stability through various ranges of motion (flexion, extension, internal/external rotation).
    • Assess leg length and femoral offset. Adjust trial components (e.g., longer/shorter femoral neck, different head length) until optimal stability, range of motion, and leg length are achieved.
11. Definitive Implantation :
    • Remove trial components.
    • Impact the definitive femoral stem, ensuring correct orientation.
    • Place the definitive femoral head (ceramic or metal).
    • Reduce the hip.
12. Closure :
    • Repair the detached short external rotators and posterior capsule. This is crucial for enhancing posterior stability and reducing dislocation risk.
    • Close the fascia lata.
    • Close subcutaneous tissue and skin layers. A drain may be inserted based on surgeon preference and intraoperative hemostasis.

HIV-Specific Intraoperative Considerations

• Bone Quality : Be prepared for potentially osteopenic or osteoporotic bone. For cementless components, ensure optimal reaming and broaching to achieve maximal primary press-fit. Consider augmented fixation (e.g., screws, cages) or use of cemented stems if bone quality is severely compromised. Use meticulous technique to prevent intraoperative fractures.
• Infection Control : Maintain an even higher level of vigilance for aseptic technique. Double gloving is standard.
• Hemostasis : Carefully monitor blood loss. PLWH may have pre-existing coagulopathies or thrombocytopenia. Transfusion thresholds should be individualized.
• Wound Healing : Meticulous skin closure and soft tissue handling are crucial to minimize wound complications. Tension-free closure should be prioritized.

Complications & Management

While modern data suggests that PLWH with well-controlled disease experience complication rates comparable to the general population following TJA, it is imperative to understand the specific risks and management strategies, especially for those with less optimized HIV status or significant comorbidities.

General Complications of Arthroplasty

1. Periprosthetic Joint Infection (PJI) : The most feared complication. Can be acute or chronic.
2. Dislocation : Often related to component malposition, soft tissue imbalance, or patient non-compliance with precautions.
3. Neurovascular Injury : Rare but devastating. Femoral or sciatic nerve injury (THA), peroneal or tibial nerve injury (TKA). Popliteal artery injury (TKA).
4. Periprosthetic Fracture : Can occur intraoperatively or postoperatively due to trauma or bone weakness.
5. Aseptic Loosening/Wear : Long-term failure due to biological response to wear particles, or poor initial fixation.
6. Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) : Thromboembolic events, requiring prophylaxis.
7. Leg Length Discrepancy (LLD) : Can cause gait disturbance and back pain.
8. Heterotopic Ossification (HO) : Formation of bone in soft tissues around the joint.
9. Wound Complications : Hematoma, seroma, dehiscence, superficial infection.

HIV-Specific Complication Profile & Management

| Complication | HIV-Specific Considerations / Incidence in PLWH (vs. HIV-negative) | Salvage/Management Strategies | | |
| PJI (General) | 1-3% (primary), 5-10% (revision) | Debridement, antibiotics, and implant retention (DAIR) for acute PJI; one-stage or two-stage revision for chronic PJI; Girdlestone or amputation for failed cases. |
| PJI (PLWH with HIV+) | Similar rates to HIV-negative with CD4 >200-350 cells/µL & undetectable viral load. May be slightly higher if CD4 <200. | Same as general, but with crucial infectious disease consult for organism identification (considering opportunistic pathogens, though rare) and ART-compatible antibiotic selection. Prolonged IV antibiotics often favored. |
| Wound Complications | Seroma/hematoma (slightly increased risk due to potential coagulopathy or thrombocytopenia). Delayed healing (possible due to immunodeficiency, malnutrition). | Drainage for hematoma/seroma. Debridement and primary closure or negative pressure wound therapy for dehiscence. Nutritional optimization. |
| Aseptic Loosening/Wear | Potentially higher risk due to altered bone metabolism, osteopenia/osteoporosis, and chronic inflammation impacting bone-implant interface. Long-term data still evolving. | Revision arthroplasty with cement, longer stems, or augments/bone grafting if bone stock is compromised. |
| Periprosthetic Fracture | Slightly increased risk due to higher prevalence of osteopenia/osteoporosis. | ORIF with plates/screws and cerclage wires. Revision with a longer or cemented stem for component instability. |
| DVT/PE | No significant difference in rates, but risk factors may overlap with HIV comorbidities. | Standard chemical (low molecular weight heparin, direct oral anticoagulants) and mechanical prophylaxis (compression devices). Extended prophylaxis may be considered for high-risk patients. |
| Drug Interactions | Crucial, as ARTs can interact with perioperative medications (analgesics, antibiotics, anticoagulants) via cytochrome P450 pathway. | Mandatory infectious disease and pharmacy consultation for medication review, dose adjustments, and alternative drug selection. Close monitoring of drug levels and patient response. |
| Immunological Rebound | Discontinuation of ART perioperatively can lead to viral rebound and immune compromise. | Strict adherence to ART throughout the perioperative period. Education of patient and healthcare team. |

Management Principles for Complications in PLWH

• Multidisciplinary Approach : Essential for managing complications in PLWH. Involve infectious disease specialists, internal medicine, nephrology, hepatology, and physical therapists.
• Aggressive Infection Management : Prompt diagnosis and aggressive treatment of any suspected infection are critical. Cultures should be taken widely, and antibiotic regimens should be tailored based on sensitivities and ART compatibility.
• Bone Health Optimization : Address underlying osteopenia/osteoporosis with appropriate medical management (Vitamin D, calcium, bisphosphonates/denosumab) to minimize future fracture risk.
• Pain Management : Be mindful of potential drug interactions when prescribing analgesics. Multimodal analgesia is preferred.
• Psychosocial Support : Address potential issues with compliance, substance use, or mental health that can impact recovery and complication rates.

Post-Operative Rehabilitation Protocols

Post-operative rehabilitation in PLWH largely follows standard protocols for TJA but requires careful consideration of the patient's overall health status, potential comorbidities, and specific HIV-related challenges. The overarching goal is to facilitate early mobilization, optimize functional recovery, and prevent complications.

General Principles of Post-Operative Rehabilitation

1. Early Mobilization : Out-of-bed activity and weight-bearing (as tolerated/directed by surgeon) are initiated on post-operative day 0 or 1. This prevents complications such as DVT/PE, atelectasis, and deconditioning.
2. Pain Management : Multimodal analgesia (opioids, NSAIDs/acetaminophen, gabapentinoids, regional nerve blocks) is crucial to facilitate participation in physical therapy.
3. DVT Prophylaxis : Continued chemical (e.g., LMWH, DOACs) and mechanical (e.g., SCDs) prophylaxis according to institutional guidelines.
4. Wound Care : Daily dressing changes, monitoring for signs of infection (erythema, swelling, drainage, fever). Drain removal when output decreases.
5. Physical Therapy (PT) and Occupational Therapy (OT) :
   • Range of Motion (ROM) Exercises : Active and passive ROM exercises to restore joint mobility.
   • Strengthening Exercises : Progressive resistive exercises for surrounding musculature.
   • Gait Training : With appropriate assistive devices (walker, crutches, cane), progressing to independent ambulation.
   • Activity of Daily Living (ADL) Training : Instruction on safe transfers, dressing, bathing, and use of adaptive equipment.
   • Weight-Bearing Restrictions : Follow surgeon's orders (e.g., protected weight-bearing for acetabular revisions, uncemented stems in poor bone quality, or periprosthetic fractures).
6. Discharge Planning : Education on home exercise program, medication regimen, activity restrictions, and signs of complications.

HIV-Specific Considerations in Rehabilitation

1. Strict ART Adherence : Emphasize the critical importance of continuing ART without interruption throughout the perioperative and rehabilitation period. Education should be reinforced at every encounter.
2. Immunological Monitoring : Continued monitoring of CD4 count and viral load to ensure HIV control. Any decline warrants prompt infectious disease review.
3. Infection Surveillance : Maintain a high index of suspicion for PJI, especially given the historical context and potential for atypical presentations in immunocompromised patients. Prompt evaluation of any fever, increasing pain, or wound changes.
4. Comorbidity Management : Ongoing management of HIV-related comorbidities such as renal disease, liver disease, cardiovascular disease, and neuropathy, which can impact rehabilitation progress and overall health.
5. Bone Health : Continuation of any pre-operative bone-sparing agents (e.g., bisphosphonates) if indicated. Encourage adequate calcium and Vitamin D intake.
6. Nutritional Support : Continue to monitor and optimize nutritional status, as malnutrition can hinder wound healing and overall recovery. Dietary counseling may be beneficial.
7. Neuropathy Management : Patients with peripheral neuropathy (a known complication of HIV or some older ARTs) may experience impaired proprioception, balance issues, and altered pain perception. Physical therapy protocols may need to be modified to account for these deficits, with increased focus on balance training and fall prevention.
8. Stamina and Fatigue : Some PLWH may experience chronic fatigue or reduced exercise tolerance, potentially impacting the intensity or duration of rehabilitation sessions. Individualized, progressive programs are essential.
9. Drug Interactions : Continuously be aware of potential drug interactions between ARTs and pain medications, antibiotics, or other drugs prescribed during rehabilitation.
10. Psychosocial Support : Address potential issues such as depression, anxiety, or social isolation, which can impact motivation and adherence to rehabilitation protocols. Connect patients with appropriate support services.
11. Long-Term Follow-up : Emphasize the need for lifelong orthopedic follow-up to monitor implant integrity, bone health, and detect late complications.

Summary of Key Literature / Guidelines

The body of literature concerning joint replacement in PLWH has grown significantly over the last two decades, reflecting the evolving understanding of HIV and advancements in ART. Key findings consistently support the safety and efficacy of TJA in appropriately selected PLWH.

• PJI Rates : Numerous meta-analyses and large cohort studies have demonstrated that PJI rates in PLWH with well-controlled HIV (CD4 count >200-350 cells/µL and undetectable viral load) are comparable to those in the HIV-negative population, typically ranging from 1-3% for primary arthroplasty. Studies that reported higher PJI rates often included patients with lower CD4 counts or detectable viral loads, underscoring the critical importance of immunological optimization. While the incidence is similar, the consequences of PJI in immunocompromised patients can still be more severe, emphasizing the need for aggressive prevention and early management.
• Other Complications : Rates of aseptic loosening, dislocation, periprosthetic fracture, and revision surgery are generally not significantly different between well-controlled PLWH and HIV-negative controls. However, some studies suggest a trend towards slightly higher rates of periprosthetic fracture, likely attributable to pre-existing osteopenia/osteoporosis.
• Functional Outcomes : Patient-reported outcomes and functional scores (e.g., Harris Hip Score, Knee Society Score) demonstrate significant improvement post-TJA in PLWH, comparable to the general population, indicating restored quality of life and functional independence.
• Role of ART : Universal consensus highlights the profound impact of ART in normalizing surgical risks. The consistent message is that effective ART, leading to a suppressed viral load and a robust CD4 count, is the single most important factor in achieving favorable outcomes.
• Recommendations/Guidelines :
  • Infectious Disease Consultation : Strongly recommended preoperatively for all PLWH undergoing TJA to optimize HIV management, review ART, and guide perioperative prophylaxis.
  • Immunological Optimization : Aim for CD4 count >200-350 cells/µL and undetectable viral load for at least 3-6 months prior to elective surgery.
  • Preoperative Screening : Comprehensive screening for comorbidities common in PLWH (cardiovascular, renal, hepatic, bone health, nutritional status) with appropriate optimization.
  • Standard Surgical Practices : Adherence to meticulous aseptic technique, careful hemostasis, and gentle soft tissue handling remain paramount.
  • Aggressive Postoperative Surveillance : Close monitoring for signs of infection or other complications.
  • Continuous ART Adherence : Emphasize uninterrupted ART throughout the perioperative period and long-term.

In conclusion, the prevailing evidence unequivocally supports that total joint arthroplasty is a safe and effective treatment option for patients living with HIV, provided their infection is well-controlled with ART and a comprehensive multidisciplinary approach is employed. The historical myths surrounding prohibitive complication rates, particularly infection, have been robustly debunked by contemporary data. Orthopedic surgeons should view HIV infection as a chronic medical condition requiring careful preoperative optimization and collaboration with infectious disease specialists, rather than an absolute contraindication to life-enhancing elective surgery. Future research will continue to explore the long-term outcomes with newer ART regimens and address specific bone quality challenges unique to this population.